The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer

Alice Melotti(University of Geneva), Ariel Ruiz i Altaba(University of Geneva), Isabel Borges(University of Geneva), Aiala Lorente‐Trigos(University of Geneva), Christophe Mas(Debiopharm (Switzerland)), Monika Kuciak(University of Geneva)
EMBO Molecular Medicine
August 20, 2014
Cited by 136


Related Papers